In patients with stable chronic heart failure, higher BMI significantly lowers NTproBNP levels, yet NTproBNP retains its prognostic power across all BMI groups.
Does obesity status (BMI) affect NT-proBNP levels and its prognostic power in patients with chronic stable heart failure?
In patients with stable heart failure, higher BMI is independently associated with lower NT-proBNP levels, but this does not diminish the biomarker's prognostic value.
Absolute Event Rate: 0% vs 0%
Even matched for NYHA, age, sex, and renal function, BMI exerts a significant and independent inverse influence on NTproBNP in patients with stable CHF. NTproBNP retained equal statistical power in all three BMI groups.
Frankenstein et al. (Tue,) reported a other. In patients with stable chronic heart failure, higher BMI significantly lowers NTproBNP levels, yet NTproBNP retains its prognostic power across all BMI groups.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: